ArticleJournal of cellular and molecular medicine2025
Construction of a Prognostic Model Using RNA Processing Factor Genes and the Key Role of NSUN6 in Glioma Outcomes.
Article in Journal of cellular and molecular medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
4 citing papers in PubMed.
- Role of RNA 5‑methylcytosine modification in cancer: Insights from coding and non‑coding RNAs (Review).Molecular medicine reports · 2026Review
- A novel risk model of cholesterol metabolism-related mRNAs for predicting overall survival and immune signature in glioma based on machine learning and multi-omics data.Translational cancer research · 2026Article
- The Role of NSUN Family Genes in m5C Methylation and Diseases.Biomedicines · 2025Review
- Construction of a Prognostic Model Using RNA Processing Factor Genes and the Key Role of NSUN6 in Glioma Outcomes.Journal of cellular and molecular medicine · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
Glioma is the most common malignant brain tumor and remains associated with a poor prognosis and limited predictive tools. The dysregulation of RNA processing factor genes has been implicated in glioma development, yet their prognostic relevance remains unclear. This study aimed to construct a robust prognostic model based on RNA processing factor genes and explore their functional roles and therapeutic potential. Transcriptomic and clinical data from glioma patients in the TCGA, CGGA, GEO and Rembrandt cohorts were analysed. Univariate, multivariate and LASSO-Cox regression analyses were performed to establish a prognostic signature. Model performance was assessed using Kaplan-Meier survival curves, time-dependent ROC analysis and C-index evaluation. Key genes were identified via random forest analysis and validated through single-cell datasets and immunohistochemistry. Functional assays were conducted to examine the biological roles of the key gene. Seventy-eight RNA processing factor genes were associated with glioma prognosis, and a 19-gene risk signature was constructed. The model effectively stratified patients into high- and low-risk groups with significantly different survival outcomes (log-rank p < 0.001). The AUCs for 1-, 3- and 5-year survival were 0.812, 0.774 and 0.769 in TCGA and 0.796, 0.758 and 0.741 in CGGA. The model achieved a C-index of 0.781 and was validated as an independent prognostic factor. NSUN6 was identified as a key protective gene whose overexpression inhibited glioma cell proliferation and migration in vitro. RNA processing factor genes have prognostic utility in glioma. The 19-gene model and NSUN6 highlight novel avenues for molecular stratification and targeted therapy.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.